SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ibrahim H Sahin, Christine A Iacobuzio-Donahue, Eileen M O’Reilly, Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy, Expert Opinion on Therapeutic Targets, 2015, 1

    CrossRef

  2. 2
    Gaurav Goel, Weijing Sun, Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future, Journal of Hematology & Oncology, 2015, 8, 1

    CrossRef

  3. 3
    Zheng Wu, Andrew Gabrielson, Jimmy J. Hwang, Michael J. Pishvaian, Louis M. Weiner, Tingting Zhuang, Lisa Ley, John L. Marshall, Aiwu Ruth He, Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer, Cancer Chemotherapy and Pharmacology, 2015, 76, 6, 1309

    CrossRef

  4. 4
    Nikhil Thiruvengadam, Walter G Park, Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward, Clinical and Translational Gastroenterology, 2015, 6, 6, e88

    CrossRef

  5. 5
    James M. Lindberg, Timothy E. Newhook, Sara J. Adair, Dustin M. Walters, Alison J. Kim, Edward B. Stelow, J. Thomas Parsons, Todd W. Bauer, Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer, Neoplasia, 2014, 16, 7, 562

    CrossRef

  6. 6
    Anna-Maria Stock, Stephan A Hahn, Gabriele Troost, Bernd Niggemann, Kurt S Zänker, Frank Entschladen, Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation, Experimental Cell Research, 2014, 326, 2, 307

    CrossRef

  7. 7
    Amedeo Amedei, Elena Niccolai, Domenico Prisco, Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy, Human Vaccines & Immunotherapeutics, 2014, 10, 11, 3354

    CrossRef

  8. 8
    Dustin M. Walters, James M. Lindberg, Sara J. Adair, Timothy E. Newhook, Catharine R. Cowan, Jayme B. Stokes, Cheryl A. Borgman, Edward B. Stelow, Bryce T. Lowrey, Maria E. Chopivsky, Tona M. Gilmer, John T. Parsons, Todd W. Bauer, Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib, Neoplasia, 2013, 15, 2, 143

    CrossRef

  9. 9
    Jae Hee Cho, Recent Update of Molecular Targeted Therapy in Pancreatic Cancer, The Korean Journal of Gastroenterology, 2013, 61, 3, 147

    CrossRef

  10. 10
    Elena Niccolai, Domenico Prisco, Mario Milco D'Elios, Amedeo Amedei, What Is Recent in Pancreatic Cancer Immunotherapy?, BioMed Research International, 2013, 2013, 1

    CrossRef

  11. 11
    Amit Mahipal, Mary J. Mcdonald, Agnieszka Witkiewicz, Brian I. Carr, Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma, Medical Oncology, 2012, 29, 1, 134

    CrossRef

  12. 12
    Matias E. Valsecchi, Mary McDonald, Jonathan R. Brody, Terry Hyslop, Boris Freydin, Charles J. Yeo, Charalambos Solomides, Stephen C. Peiper, Agnieszka K. Witkiewicz, Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma, Cancer, 2012, 118, 14
  13. 13
    Pelin Cinar, Margaret A. Tempero, Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer, The Cancer Journal, 2012, 18, 6, 653

    CrossRef

  14. 14
    John F. Kuemmerle, John A. Barnard, Kirk M. McHugh, Physiology of the Gastrointestinal Tract, 2012,

    CrossRef

  15. 15
    Khaldoun Almhanna, Philip A. Philip, Defining New Paradigms for the Treatment of Pancreatic Cancer, Current Treatment Options in Oncology, 2011, 12, 2, 111

    CrossRef

  16. 16
    Veronica Dudu, Veronica Rotari, Maribel Vazquez, Targeted extracellular nanoparticles enable intracellular detection of activated epidermal growth factor receptor in living brain cancer cells, Nanomedicine: Nanotechnology, Biology and Medicine, 2011, 7, 6, 896

    CrossRef

  17. 17
    David Berz, Harold Wanebo, Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors, Journal of Surgical Oncology, 2011, 103, 6
  18. 18
    Yuko Kuboki, Keiko Shiratori, Takashi Hatori, Izumi Fujita, Akira Kimijima, Masakazu Yamamoto, Makio Kobayashi, Toru Furukawa, Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas, Modern Pathology, 2010, 23, 8, 1127

    CrossRef

  19. 19
    Andrey Frolov, J. Spencer Liles, Andrew V. Kossenkov, Ching-Wei D. Tzeng, Nirag Jhala, Peter Kulesza, Shyam Varadarajulu, Mohamad Eloubeidi, Martin J. Heslin, J. Pablo Arnoletti, Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma, The American Journal of Surgery, 2010, 200, 3, 398

    CrossRef

  20. 20
    Frank Bergmann, Gerhard Moldenhauer, Esther Herpel, Matthias M Gaida, Oliver Strobel, Jens Werner, Irene Esposito, Susanne Sebens Müerköster, Peter Schirmacher, Michael A Kern, Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?, Histopathology, 2010, 56, 4
  21. 21
    F. Rückert, D. Aust, C. Pilarsky, R. Grützmann, Molekularbiologie des Pankreaskarzinoms, Der Onkologe, 2010, 16, 6, 557

    CrossRef

  22. 22
    Jonathan R Brody, Christina L Costantino, Magdalena Potoczek, Joseph Cozzitorto, Peter McCue, Charles J Yeo, Ralph H Hruban, Agnieszka K Witkiewicz, Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma, Modern Pathology, 2009, 22, 5, 651

    CrossRef

  23. 23
    J R Tysome, A Briat, G Alusi, F Cao, D Gao, J Yu, P Wang, S Yang, Z Dong, S Wang, L Deng, J Francis, T Timiryasova, I Fodor, N R Lemoine, Y Wang, Lister strain of vaccinia virus armed with endostatin–angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer, Gene Therapy, 2009, 16, 10, 1223

    CrossRef

  24. 24
    Ghassan El Maalouf, Christophe Le Tourneau, Georges Nicolas Batty, Sandrine Faivre, Eric Raymond, Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer, Cancer Treatment Reviews, 2009, 35, 2, 167

    CrossRef

  25. 25
    Malte Buchholz, Thomas M Gress, Molecular changes in pancreatic cancer, Expert Review of Anticancer Therapy, 2009, 9, 10, 1487

    CrossRef

  26. 26
    Han Hsi Wong, Nicholas R. Lemoine, Biological Approaches to Therapy of Pancreatic Cancer, Pancreatology, 2008, 8, 4-5, 431

    CrossRef

  27. 27
    Ulrich Mayr, Alexander von Werder, Barbara Seidler, Wolfgang Reindl, Monther Bajbouj, Roland M. Schmid, Günter Schneider, Dieter Saur, RCAS-Mediated Retroviral Gene Delivery: A Versatile Tool for the Study of Gene Function in a Mouse Model of Pancreatic Cancer, Human Gene Therapy, 2008, 19, 9, 896

    CrossRef

  28. 28
    S. A. Danovi, H. H. Wong, N. R. Lemoine, Targeted therapies for pancreatic cancer, British Medical Bulletin, 2008, 87, 1, 97

    CrossRef

  29. 29
    Mi-Ae Lyu, Razelle Kurzrock, Michael G. Rosenblum, The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines, Biochemical Pharmacology, 2008, 75, 4, 836

    CrossRef

  30. 30
    David Berz, Thomas Miner, Elise McCormack, Howard Safran, HER family inhibitors in pancreatic cancer: current status and future directions, Expert Opinion on Therapeutic Targets, 2007, 11, 3, 337

    CrossRef

  31. 31
    Jeeyun Lee, Kee-Taek Jang, Chang-Seok Ki, Taekyu Lim, Young Suk Park, Ho Yeong Lim, Dong-Wook Choi, Won Ki Kang, Keunchil Park, Joon Oh Park, Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma, Cancer, 2007, 109, 8
  32. 32
    Günter Schneider, Dieter Saur, Roland M. Schmid, Pancreatic cancer — Molecular alterations, The Chinese-German Journal of Clinical Oncology, 2007, 6, 2, 102

    CrossRef

  33. 33
    Benedito A. Carneiro, Randall E. Brand, Elita Fine, Richard H. Knop, Janardan D. Khandekar, William Uhlig, Gershon Y. Locker, Phase I Trial of Fixed Dose Rate Infusion Gemcitabine with Gefitinib in Patients with Pancreatic Carcinoma, Cancer Investigation, 2007, 25, 5, 366

    CrossRef

  34. 34
    Martin Loos, Frank Bergmann, Andrea Bauer, Jörg D. Hoheisel, Irene Esposito, Jörg Kleeff, Peter Schirmacher, Markus W. Büchler, Günter Klöppel, Helmut Friess, Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature, Virchows Archiv, 2007, 450, 6, 719

    CrossRef

  35. 35
    Elena Ortiz-Zapater, Sandra Peiró, Oriol Roda, Josep M. Corominas, Susana Aguilar, Coral Ampurdanés, Francisco X. Real, Pilar Navarro, Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2, The American Journal of Pathology, 2007, 170, 5, 1573

    CrossRef

  36. 36
    Kenneth L van Golen, Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?, Expert Opinion on Therapeutic Targets, 2006, 10, 5, 709

    CrossRef

  37. 37
    U Graeven, B Kremer, Th Südhoff, B Killing, F Rojo, D Weber, J Tillner, C ünal, W Schmiegel, Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer, British Journal of Cancer, 2006, 94, 9, 1293

    CrossRef

  38. 38
    Naureen Starling, John Neoptolemos, David Cunningham, Role of erlotinib in the management of pancreatic cancer, Therapeutics and Clinical Risk Management, 2006, 2, 4, 435

    CrossRef

  39. 39
    John A. Barnard, Kirk M. McHugh, Physiology of the Gastrointestinal Tract, 2006,

    CrossRef

  40. 40
    Shioto Suzuki, Yoh Dobashi, Hiroyuki Sakurai, Keiichi Nishikawa, Mitsuhiko Hanawa, Akishi Ooi, Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas, Cancer, 2005, 103, 6
  41. 41
    Pedro J Ramírez, Selwyn M Vickers, Adenoviral gene therapy for pancreatic adenocarcinoma, Current Surgery, 2004, 61, 4, 351

    CrossRef

  42. 42
    Pedro J Ramírez, Selwyn M Vickers, Current status of gene therapy for pancreatic cancer, Current Surgery, 2004, 61, 1, 84

    CrossRef

  43. 43
    Mary J MacKenzie, Molecular therapy in pancreatic adenocarcinoma, The Lancet Oncology, 2004, 5, 9, 541

    CrossRef

  44. 44
    Takuo Takehana, Kazuyoshi Kunitomo, Shioto Suzuki, Koji Kono, Hideki Fujii, Yoshiro Matsumoto, Akishi Ooi, Expression of epidermal growth factor receptor in gastric carcinomas, Clinical Gastroenterology and Hepatology, 2003, 1, 6, 438

    CrossRef

  45. 45
    Joe Matsumoto, Masako Kaneda, Mitsuhiro Tada, Jun-ichi Hamada, Shunichi Okushiba, Satoshi Kondo, Hiroyuki Katoh, Tetsuya Moriuchi, Differential Mechanisms of Constitutive Akt/PKB Activation and Its Influence on Gene Expression in Pancreatic Cancer Cells, Japanese Journal of Cancer Research, 2002, 93, 12
  46. 46
    J. Feng, N. V. Adsay, M. Kruger, K. L. Ellis, K. Nagothu, A. P. N. Majumdar, F. H. Sarkar, Expression of ERRP in Normal and Neoplastic Pancreata and Its Relationship to Clinicopathologic Parameters in Pancreatic Adenocarcinoma, Pancreas, 2002, 25, 4, 342

    CrossRef

  47. 47
    Bence Sipos, Dirk Weber, Hendrik Ungefroren, Holger Kalthoff, Andre Zühlsdorff, Claudia Luther, Virag Török, Günter Klöppel, Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: An in vitro and in vivo study, International Journal of Cancer, 2002, 102, 6
  48. 48
    James D. Evans, Philip A. Cornford, Andrew Dodson, William Greenhalf, Christopher S. Foster, John P. Neoptolemos, Detailed Tissue Expression of bcl-2, bax, bak and bcl-x in the Normal Human Pancreas and in Chronic Pancreatitis, Ampullary and Pancreatic Ductal Adenocarcinomas, Pancreatology, 2001, 1, 3, 254

    CrossRef

  49. 49
    Bertram Poch, Frank Gansauge, Andreas Schwarz, Thomas Seufferlein, Thomas Schnelldorfer, Marco Ramadani, Hans G. Beger, Susanne Gansauge, Epidermal Growth Factor Induces Cyclin D1 in Human Pancreatic Carcinoma: Evidence for a Cyclin D1–Dependent Cell Cycle Progression, Pancreas, 2001, 23, 3, 280

    CrossRef

  50. 50
    John Barnard, Epidermal growth factor receptor blockade: An emerging therapeutic modality in gastroenterology, Gastroenterology, 2001, 120, 7, 1872

    CrossRef

  51. 51
    G.H. Sakorafas, A.G. Tsiotou, G.G. Tsiotos, Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective, Cancer Treatment Reviews, 2000, 26, 1, 29

    CrossRef

  52. 52
    Richard A. Perugini, Theodore P. McDade, Frank J. Vittimberga, Mark P. Callery, Pancreatic Cancer Cell Proliferation Is Phosphatidylinositol 3-Kinase Dependent, Journal of Surgical Research, 2000, 90, 1, 39

    CrossRef

  53. 53
    ROLAND M. SCHMID, GÜNTHER KLÖPPEL, GUIDO ADLER, MARTIN WAGNER, Acinar-Ductal-Carcinoma Sequence in Transforming Growth Factor-α Transgenic Mice, Annals of the New York Academy of Sciences, 1999, 880, 1
  54. 54
    Didier Ferbus, Aude Fléchon, Martine Muleris, Yong Li, Samir Hanash, Benoît Terris, Pascal Hammel, Laurence Pibouin, Bernard Dutrillaux, Gérard Goubin, Amplification and over-expression of OZF, a gene encoding a zinc finger protein, in human pancreatic carcinomas, International Journal of Cancer, 1999, 80, 3
  55. 55
    Suresh T. Chari, Eugene P. DiMagno, Chronic pancreatitis, Current Opinion in Gastroenterology, 1999, 15, 5, 398

    CrossRef

  56. 56
    Attila Zalatnai, Epidermal growth factor receptor, somatostatin and Bcl-2 in human pancreatic tumor xenografts, Pathology & Oncology Research, 1999, 5, 2, 146

    CrossRef

  57. 57
    HELMUT FRIESS, XIAO-ZHONG GUO, BI-CHENG NAN, ÖRG KLEEFF, MARKUS W. BÜCHLER, Growth Factors and Cytokines in Pancreatic Carcinogenesis, Annals of the New York Academy of Sciences, 1999, 880, 1
  58. 58
    Charles J. Yeo, John L. Cameron, Pancreatic cancer, Current Problems in Surgery, 1999, 36, 2, 57

    CrossRef

  59. 59
    MICHAEL A. HOLLINGSWORTH, Proteins Expressed by Pancreatic Duct Cellsand Their Relatives, Annals of the New York Academy of Sciences, 1999, 880, 1
  60. 60
    LUCIE JONES, PAULA GHANEH, MICHELLE HUMPHREYS, JOHN P. NEOPTOLEMOS, The Matrix Metalloproteinases and Their Inhibitors in the Treatment of Pancreatic Cancer, Annals of the New York Academy of Sciences, 1999, 880, 1
  61. 61
    Bruce A. Ruggeri, Lingyi Huang, Moira Wood, Jin Quan Cheng, Joseph R. Testa, Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas, Molecular Carcinogenesis, 1998, 21, 2
  62. 62
    Ni Liu, Toru Furukawa, Masao Kobari, Ming-Sound Tsao, Comparative Phenotypic Studies of Duct Epithelial Cell Lines Derived from Normal Human Pancreas and Pancreatic Carcinoma, The American Journal of Pathology, 1998, 153, 1, 263

    CrossRef

  63. 63
    Ademmer, Ebert, MÜller-Ostermeyer, Friess, BÜchler, Schubert, Malfertheiner, Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+ CD18+ cells and CD8+ CD103+ cells by multi-epitope imaging, Clinical & Experimental Immunology, 1998, 112, 1
    Direct Link:
  64. 64
    Haycox, Lombard, Neoptolemos, Walley, Review article: current treatment and optimal patient management in pancreatic cancer, Alimentary Pharmacology & Therapeutics, 1998, 12, 10
  65. 65
    W. Schmiegel, J. Schmielau, D. Henne-Bruns, H. Juhl, C. Roeder, P. Buggisch, A. Onur, B. Kremer, H. Kalthoff, E. V. Jensen, Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer, Proceedings of the National Academy of Sciences, 1997, 94, 23, 12622

    CrossRef

  66. 66
    Soon C. Lee, Anna Redshaw, Guy Boag, Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma, Pathology, 1997, 29, 3, 251

    CrossRef

  67. 67
    Yoshinori Murakami, Genetic alterations in human pancreatic cancer, Journal of Hepato-Biliary-Pancreatic Surgery, 1997, 4, 3
  68. 68
    Carmen C. Solorzano, Shawn C. Jones, Mark Pettitjean, Thomas G. O'Daniel, Troy Auffenberg, Philip G. Woost, Edward M. Copeland, Lyle L. Moldawer, Gregory S. Schultz, Sally L. D. MacKay, Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-α antibodies and tyrphostin, Annals of Surgical Oncology, 1997, 4, 8, 670

    CrossRef

  69. 69
    Jean -Bernard Dietrich, AR4-2J cells: A model to study polypeptide hormone receptors, Bioscience Reports, 1996, 16, 4, 273

    CrossRef

  70. 70
    PRADEEP VAIDYA, YOSHIFUMI KAWARADA, TAKASHI HIGASHIGUCHI, TOSHIMICHI YOSHIDA, TERUYO SAKAKURA, RYUICHI YATANI, OVEREXPRESSION OF DIFFERENT MEMBERS OF THE TYPE 1 GROWTH FACTOR RECEPTOR FAMILY AND THEIR ASSOCIATION WITH CELL PROLIFERATION IN PERIAMPULLARY CARCINOMA, The Journal of Pathology, 1996, 178, 2
  71. 71
    Tsutomu Tomioka, Ilia Toshkov, Katherine Kazakoff, Åke Andrén-Sandberg, Toshiyuki Takahashi, Markus Büchler, Helmut Friess, Rick Vaughn, Parviz M. Pour, Cellular and subcellular localization of transforming growth factor-α and epidermal growth factor receptor in normal and diseased human and hamster pancreas, Teratogenesis, Carcinogenesis, and Mutagenesis, 1995, 15, 5
  72. 72
    C.S. Lee, A. Pirdas, Epidermal Growth Factor Receptor Immunoreactivity in Gallbladder and Extrahepatic Biliary Tract Tumours, Pathology - Research and Practice, 1995, 191, 11, 1087

    CrossRef

  73. 73
    John A. Barnard, R. Daniel Beauchamp, William E. Russell, Raymond N. Dubois, Robert J. Coffey, Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology, Gastroenterology, 1995, 108, 2, 564

    CrossRef

  74. 74
    J. MacCallum, R. Poulsom, A.M. Hanby, W.R. Miller, Expression and distribution of TGFβ mRNA isoforms in a small group of human breast cancers examined by in situ hybridization, The Breast, 1995, 4, 4, 289

    CrossRef

  75. 75
    Richard M Schultz, Section Review: Oncologic, Endocrine & Metabolic: Future directions for the treatment of human pancreatic carcinoma, Expert Opinion on Investigational Drugs, 1995, 4, 12, 1273

    CrossRef

  76. 76
    D. J. Hastrich, J. M. Dunn, S. Nicholson, P. Newcomb, J. R. Farndon, Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer, British Journal of Surgery, 1994, 81, 6
  77. 77
    Astrid Mayer, Masafumi Takimoto, Elke Fritz, Georgine Schellander, Klaus Kofler, Heinz Ludwig, The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer, Cancer, 1993, 71, 8
  78. 78
    Nicholas R. Lemoine, Maria Lobresco, Hing Leung, Claire Barton, Christine M. Hughes, Sally A. Prigent, William J. Gullick, Günter Klöppel, The erbB-3 Gene in human pancreatic cancer, The Journal of Pathology, 1992, 168, 3